Latest Ask the Experts
Managing Targeted Therapy in CLL
When treating CLL with targeted therapy, what is your strategy for educating patients about adverse events?
Polycythemia Vera
What is the role of phlebotomy in the treatment of patients with polycythemia vera (PV)?
Latest How I Treat
Chronic Lymphocytic Leukemia: A Nursing Perspective
Nurses are on the forefront as health care providers in the care of patients with chronic lymphocytic leukemia receiving oral oncolytic therapy.
Latest Case Studies
Myelofibrosis: From Diagnosis to Early Intervention
In this Case Study, Ms Lyle discusses diagnosis and early management of myelofibrosis in a 72-year-old male patient.
Case Study: Polycythemia Vera: Diagnosis Through CBC Management With Ruxolitinib
This case follows a 35-year-old man with polycythemia vera from presentation in the ED through initiating and modifying treatment with phlebotomy and hydroxyurea, and eventually achieving optimal management of symptoms and CBC with ruxolitinib.
Sign Up for Free e-newsletters
ONA Articles
- Proscription on Antiperspirant Use During Radiotherapy: Does the Advice Still Apply?
- Recommended Therapies for Polycythemia Vera Underused
- FDA Grants Approval to New Treatment for Acute Myeloid Leukemia
- Rituximab Biosimilar CT-P10 Equivalent as Monotherapy for Follicular Lymphoma
- Stringent Complete Response Criteria for Patients With Multiple Myeloma May Lack Predictive Value
- Smartphone App Improves Management of Cancer-Related Pain, Anxiety
- Counseling Patients on Oral Chemotherapy
- Lung Cancer-Specific Distress Screening Tool Not Needed But Has Potential Benefit
- Prophylaxis Improves Postchemotherapy Nausea/Vomiting Frequency, Hospitalizations
- How to Help Patients at the End of Life and Their Loved Ones During the Holidays
- Expression of Chemerin Correlates With a Poor Prognosis in Female Breast Cancer Patients
- Proscription on Antiperspirant Use During Radiotherapy: Does the Advice Still Apply?
- Recommended Therapies for Polycythemia Vera Underused
- Stringent Complete Response Criteria for Patients With Multiple Myeloma May Lack Predictive Value
- Rituximab Biosimilar CT-P10 Equivalent as Monotherapy for Follicular Lymphoma
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |